tirzepatide 2022 New Blockbuster Type 2 Medication Mounjaro Gets FDA Approval Tirzepatide is a New Medication

Association of bariatric surgery with cancer risk and mortality in adults with obesity

The quality of calories consumed affects energy levels, nutrient status, and body composition

But for others, especially those with a sensitive digestive system, the impact on gut movement can be significant

In rare cases, it can also cause serious cardiovascular side effects, including heart attack, stroke, and sudden cardiac death (heart suddenly stops beating)

The other says supplements do nothing at all

Semaglutide is clinically indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as Type 2 diabetes, hypertension, high cholesterol, or cardiovascular disease